Investigating the role of a specific protein in blood cancer development
The role of YTHDC1 in normal and malignant hematopoiesis
This study is looking at how a protein called YTHDC1 affects the way normal blood cells can turn into leukemia cells, with the hope of finding new treatments to help people with acute myeloid leukemia (AML).
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-11076671 on NIH RePORTER |
What this research studies
This research focuses on understanding how the protein YTHDC1 influences the development of acute myeloid leukemia (AML), a common type of blood cancer. The study examines the role of m6A RNA methylation, a modification that affects gene expression, in the transformation of normal blood stem cells into leukemia stem cells. By exploring the mechanisms of YTHDC1 in AML, researchers aim to uncover potential targets for new therapies that could improve treatment outcomes for patients with this disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with acute myeloid leukemia or those at risk of developing this condition.
Not a fit: Patients with other types of leukemia or blood disorders unrelated to acute myeloid leukemia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of targeted therapies for acute myeloid leukemia, improving survival rates and treatment options for patients.
How similar studies have performed: Previous research has shown promising results in targeting RNA modifications in cancer, suggesting that this approach could be effective in treating acute myeloid leukemia as well.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Qian, Zhijian — University of Florida
- Study coordinator: Qian, Zhijian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.